Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adept, AJT, ALARM, AlloCare, AlloCell, allogeneic, AUC, Avantor, Biden, biopharma, BK, blocking, bloodstream, Bloom, Blue, Brazil, caregiver, Century, China, chose, codify, contemplate, contradict, contrast, Cornell, counsel, counterparty, covertly, curb, curve, cybersecurity, cycle, De, deliberate, dental, disability, disagree, disorder, diversification, downloaded, duration, easily, EKRA, engraftment, equitable, ESRD, evolution, excelling, explanation, exploit, FFS, fit, fundamentally, gathered, Geisinger, genotyping, Governor, greatest, Hamilton, harbor, histologic, house, Immuno, infected, infection, inflammation, Inspector, interaction, interfering, intervene, judged, Korea, leadership, loosening, magnitude, marker, Mateo, Mexico, movement, nationwide, Novo, onboarding, online, onsite, overallotment, overtly, pandemic, permissible, permission, persistence, philosophy, phlebotomy, polymorphism, precautionary, prioritization, prison, privileged, proteinuria, purportedly, recession, recover, remote, remotely, RemoTraC, reopen, repetitive, resurgence, retirement, retransplantation, risky, rulemaking, safe, salary, scalable, Shield, Singapore, slowdown, SNP, somatic, speaker, spite, stay, surrogate, talent, TCMR, tightening, timeline, tolerated, top, TransChart, ubiquity, unexpected, unprecedented, uptake, Veracyte, viremia, Wuhan, XynCare
Filing tables
Filing exhibits
Related press release
Associated CDNA transcripts
CDNA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 Nos. 333-211700, 333-227168, and 333-239049, on Form S-1 Nos. 333-217461, 333-220183, and on Form S-8 Nos. 333-197493, 333-203128, 333-211538, 333-217462, 333-225991, 333-231523, 333-233710, and 333-239277 of our reports dated February 24, 2021, relating to the consolidated financial statements of CareDx, Inc. and its subsidiaries (the “Company”) , and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
San Jose, California
February 24, 2021